Skip to main content

Csenge Advisory Group

SEC CIK
0001715593
Latest filing
Aug 10, 2026

ELV holding history

Elevance Health, Inc. in every 13F filed by Csenge Advisory Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ELV overviewAll 13F holders of ELVFull Q2 2026 holdings

Shares (Q2 2026)
3,726
Value
$1.44M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of ELV by Csenge Advisory Group, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,726$1.44M0.1%+648+21.1%AddedHolders
Q1 20263,078$900.9K<0.1%−105−3.3%ReducedHolders
Q4 20253,183$1.12M0.1%−6−0.2%ReducedHolders
Q3 20253,189$1.03M<0.1%−282−8.1%ReducedHolders
Q2 20253,471$1.33M0.1%−26−0.7%ReducedHolders
Q1 20253,497$1.48M0.1%+87+2.6%AddedHolders
Q4 20243,410$1.26M0.1%−1,250−26.8%ReducedHolders
Q3 20244,660$2.34M0.1%+592+14.6%AddedHolders
Q2 20244,068$2.20M0.1%+77+1.9%AddedHolders
Q1 20243,991$2.07M0.1%−51−1.3%ReducedHolders
Q4 20234,042$1.91M0.1%−155−3.7%ReducedHolders
Q3 20234,197$1.83M0.1%+238+6.0%AddedHolders
Q2 20233,959$1.76M0.1%−154−3.7%ReducedHolders
Q1 20234,113$1.89M0.1%+77+1.9%AddedHolders
Q4 20224,036$2.07M0.2%−135−3.2%ReducedHolders
Q3 20224,171$1.90M0.2%−231−5.2%ReducedHolders
Q2 20224,402$2.12M0.2%+534+13.8%AddedHolders
Q1 20223,868$1.90M0.2%+591+18.0%AddedHolders
Q4 20213,277$1.26M0.1%−24−0.7%ReducedHolders
Q3 20213,301$1.24M0.1%+24+0.7%AddedHolders
Q2 20213,277$1.26M0.1%+2,588+375.6%AddedHolders
Q1 2021689$249.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.